John Finlator

Last updated
John H. Finlator
John Finlator 1967.png
Director Bureau of Drug Abuse Control
In office
March 7, 1966 –April 8, 1968

John Haywood Finlator was an American federal administrator and narcotics law enforcement director. He was the first and only director of the Bureau of Drug Abuse Control (BDAC), and later served as deputy director of the Bureau of Narcotics and Dangerous Drugs (BNDD). [1] [2] He was one of the first members of the narcotics enforcement community that advocated for decriminalizing cannabis and marijuana. This advocacy often set him at odds with his coworkers at the bureau and with Congress but was praised by many medical community members. [3]

Contents

Early life

Finlator was born in 1911 in Louisburg, North Carolina. [4] He earned a bachelor's degree in history and economics from North Carolina State University, and a master's degree in management from American University. [5] He was a member of the Cosmos Club and the Sons of the American Revolution. [5]

Career in public service

In 1937, Finlator became a postal clerk for the United States Post Office Department in North Carolina. [5] At some point, Finlator worked as an investigator for the Civil Service Commission. [5] At some point, Finlator was appointed to be the Director of the Office of Manpower Administration for the General Services Administration. [5]

In 1941, Finlator moved to Washington, D.C. and joined the State Department, where he worked administrative jobs. [5] By 1954, Finlator was the Executive Officer for the State Department's Office of Security, and the Acting Chief of that office's Division of Investigations. [6]

Director of the Bureau of Drug Abuse Control

John Finlator and Kenneth Durrin waiting for a new class of BDAC recruits. BDAC instructors.png
John Finlator and Kenneth Durrin waiting for a new class of BDAC recruits.

On March 7, 1966, Finlator was appointed the first Director of the BDAC by Dr. James L. Goddard. [7] Finlator served as the first and only director of the bureau. [7] Officially, Finlator spoke against marijuana, and in favor of convictions while in this office. [8]

There was a differentiation between the Federal Bureau of Narcotics (FBN) and the BDAC here: FBN had jurisdiction over narcotics such as marijuana, cocaine, opium, and their derivatives. [2] BDAC had jurisdiction over those other drugs that were considered "dangerous drugs", including LSD and hallucinogenics. Marijuana was not in Finlator's remit or vested enumerated power to pursue, and vise-versa, the FBN did not pursue LSD. However, charges in LSD arrests made by BDAC incidentally sometimes included charges of possession of marijuana. [9] Finlator also wrote that marijuana would often be laced with LSD, confusing the jurisdictional pursuit of LSD. [10] Under Finlator's leadership, the BDAC seized millions of units of hallucinogenic drugs, most of it LSD. [7]

Finlator's BDAC clashed against the culture of the FBN, because his approach was a nontraditional law enforcement approach which he called the "statistical-psychological-educational" approach. [11] This model defined the structure of BDAC and its three branches, and the modus of the basic BDAC operations. [11] Finlator wanted an agency that stood apart from the FBN here, in that he wanted to treat drug addiction as a medical issue, and direct his agency to study and work with doctors and the medical community to address the roots of the problems that result in addiction. In sum, BDAC treated addicts like people - while the FBN treated addicts as deviants who should be prosecuted with the full force of the law. [11]

Finlator came to BDAC with a different approach than most other cops was because he was not a cop, and he did not have a background in law enforcement. [11] Finlator was a "soft spoken" administrator, but he originally gained the respect of the policing community because he looked the part and was able to secure convictions. [11] BDAC was also not a traditional law enforcement unit - it belonged to the FDA, which came with a medical approach to drugs and not a police approach. [11]

Bureau of Narcotics and Dangerous Drugs

On April 8, 1968, Finlator was re-delegated by Attorney General Ramsey Clark to the position of assistant director of the newly established Bureau of Narcotics and Dangerous Drugs (BNDD), where he would keep his pay and grade. [12] He was transferred on the same day as Henry Giordano, the Commissioner of the FBN. [12] Finlator was later promoted to deputy director of the agency.

On January 1, 1972, Finlator tendered his resignation. [13] He resigned at 60 years of age, and 57 was the mandatory retirement age for most federal law enforcement employees. [14] However, the press of the day reported that he quit the job over his disagreements with marijuana legislation. [15]

Advisory Board of NORML

John Finlator testifies for marijuana reform before the Senate and House Judiciary Committees in 1973. John Finlator testifies.png
John Finlator testifies for marijuana reform before the Senate and House Judiciary Committees in 1973.

Before Finlator officially retired, he had given several speeches and public notices on his opinion that marijuana should be decriminalized. [16] Keith Stroup, the founding director of the National Organization for the Reform of Marijuana Laws (NORML) contacted Finlator and asked him if he would like to join. Finlator told him to call back after he was no longer serving in the federal government. [16]

On the same evening after Finlator tendered his resignation, he received a telephone call from Stroup asking him again to join the founding advisory board of the nascent pro-reform organization. [16] Finlator agreed, officially joining the advisory board. He was referred to as part of the "traveling road show," by the organization, testifying before state and local governments across the country as a key witness for decriminalization. [17] He also represented the organization in Washington. [18]

Stroup writes of his interactions with Finlator in the early days of NORML:

"Finlator seemed to enjoy the surprise on people's faces when he testified in favor of marihuana decriminalization... I offered Finlator marijuana on several occasions, when we were spending a night in some hotel on the road waiting to testify the next day before some state legislature, but he always laughed and declined. Those of us who smoked would often meet in my room and share a joint before dinner, where Finlator and Whipple would join us and make jokes about our being stoned. They, of course, enjoyed a cocktail or two with dinner." [19]

Retirement and later life

In 1973, Finlator wrote the book The Drugged Nation: A Narc's story. [20] [21] Later he wrote several works of poetry.

Finlator lived in Arlington, Virginia for 44 years. He served as President of the Arlington Kiwanis Club and chairman of the Arlington Red Cross. He also served on the Arlington Salvation Army board and the Hospice of Northern Virginia. [5] He was a member of Clarendon United Methodist Church in Arlington. [5]

On August 17, 1990, Finlator died of cancer at the Hermitage Health Center in Alexandria, Virginia. [5]

Related Research Articles

<span class="mw-page-title-main">Controlled Substances Act</span> United States drug-regulating law

The Controlled Substances Act (CSA) is the statute establishing federal U.S. drug policy under which the manufacture, importation, possession, use, and distribution of certain substances is regulated. It was passed by the 91st United States Congress as Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970 and signed into law by President Richard Nixon. The Act also served as the national implementing legislation for the Single Convention on Narcotic Drugs.

<span class="mw-page-title-main">Drug Enforcement Administration</span> United States federal law enforcement agency

The Drug Enforcement Administration (DEA) is a United States federal law enforcement agency under the U.S. Department of Justice tasked with combating illicit drug trafficking and distribution within the U.S. It is the lead agency for domestic enforcement of the Controlled Substances Act, sharing concurrent jurisdiction with the Federal Bureau of Investigation, the U.S. Immigration and Customs Enforcement, and U.S. Customs and Border Protection. However, the DEA has sole responsibility for coordinating and pursuing U.S. drug investigations both domestically and internationally.

The National Organization for the Reform of Marijuana Laws is a social welfare organization based in Washington, D.C., that advocates for the reform of marijuana laws in the United States regarding both medical and non-medical use. According to their website, NORML supports "the removal of all penalties for the private possession and responsible use of marijuana by adults, including cultivation for personal use, and casual nonprofit transfers of small amounts" and advocates for "the creation of a legal and regulatory framework for marijuana's production and retail sale to adults". NORML also has a sister organization, NORML Foundation, that focuses on educational efforts and providing legal assistance and support to people affected negatively by current marijuana laws. NORML maintains chapters in a number of US states as well as outside the US in countries such as Canada, France, New Zealand, and South Africa.

<span class="mw-page-title-main">War on drugs</span> Global anti-drug campaign led by the United States

The war on drugs is the policy of a global campaign, led by the United States federal government, of drug prohibition, military aid, and military intervention, with the aim of reducing the illegal drug trade in the United States. The initiative includes a set of drug policies that are intended to discourage the production, distribution, and consumption of psychoactive drugs that the participating governments, through United Nations treaties, have made illegal.

<span class="mw-page-title-main">Keith Stroup</span>

Keith Stroup is an American attorney and founder of the National Organization for the Reform of Marijuana Laws.

<span class="mw-page-title-main">Removal of cannabis from Schedule I of the Controlled Substances Act</span> Proposed changes to the legal status of cannabis in U.S. federal law

In the United States, the removal of cannabis from Schedule I of the Controlled Substances Act, the category reserved for drugs that have "no currently accepted medical use", is a proposed legal and administrative change in cannabis-related law at the federal level. After being proposed repeatedly since 1972, the U.S. Department of Justice initiated 2024 rulemaking to reschedule cannabis to Schedule III of the Controlled Substances Act. The majority of 2024 public comments supported descheduling, decriminalizing, or legalizing marijuana at the federal level.

<span class="mw-page-title-main">Bureau of Narcotics and Dangerous Drugs</span> Former U.S. Department of Justice narcotics enforcement bureau

The Bureau of Narcotics and Dangerous Drugs (BNDD) was a federal law enforcement agency within the United States Department of Justice with the enumerated power of investigating the consumption, trafficking, and distribution of narcotics and dangerous drugs. BNDD is the direct predecessor of the modern Drug Enforcement Administration (DEA).

<span class="mw-page-title-main">Federal Bureau of Narcotics</span> Defunct agency of the US Department of the Treasury

The Federal Bureau of Narcotics (FBN) was an agency of the United States Department of the Treasury, with the enumerated powers of pursuing crimes related to the possession, distribution, and trafficking of listed narcotics including cannabis, opium, cocaine, and their derivatives. Headquartered in Washington, D.C., the FBN carried out operations and missions around the world. The bureau was in existence from its establishment in 1930 until its dissolution in 1968. FBN is considered a predecessor to the Drug Enforcement Administration.

<span class="mw-page-title-main">Bureau of Drug Abuse Control</span> Former narcotics law enforcement bureau of the FDA

The Bureau of Drug Abuse Control (BDAC) was an American law enforcement agency that investigated the consumption, trafficking, and distribution of drugs and controlled substances. BDAC was a Bureau of the Food and Drug Administration (FDA). In the sum total of the two years that BDAC existed, it investigated and closed around 300 criminal cases, seized 43 clandestine drug laboratories, and made over 1,300 arrests.

<span class="mw-page-title-main">Legalization of non-medical cannabis in the United States</span>

In the United States, the non-medical use of cannabis is legalized in 24 states and decriminalized in 7 states, as of November 2023. Decriminalization refers to a policy of reduced penalties for cannabis offenses, typically involving a civil penalty for possessing small amounts, instead of criminal prosecution or the threat of arrest. In jurisdictions without penalty the policy is referred to as legalization, although the term decriminalization is sometimes used for this purpose as well.

<span class="mw-page-title-main">Legal history of cannabis in the United States</span>

In the United States, increased restrictions and labeling of cannabis as a poison began in many states from 1906 onward, and outright prohibitions began in the 1920s. By the mid-1930s cannabis was regulated as a drug in every state, including 35 states that adopted the Uniform State Narcotic Drug Act. The first national regulation was the Marihuana Tax Act of 1937.

<span class="mw-page-title-main">Federal drug policy of the United States</span> Nationwide framework regarding the abuse of drugs in the United States

The drug policy in the United States is the activity of the federal government relating to the regulation of drugs. Starting in the early 1900s, the United States government began enforcing drug policies. These policies criminalized drugs such as opium, morphine, heroin, and cocaine outside of medical use. The drug policies put into place are enforced by the Food and Drug Administration and the Drug Enforcement Administration. Classification of Drugs are defined and enforced using the Controlled Substance Act, which lists different drugs into their respective substances based on its potential of abuse and potential for medical use. Four different categories of drugs are Alcohol, Cannabis, Opioids, and Stimulants.

<span class="mw-page-title-main">Drug liberalization</span> Process of reducing drug prohibition laws

Drug liberalization is a drug policy process of decriminalizing, legalizing, or repealing laws that prohibit the production, possession, sale, or use of prohibited drugs. Variations of drug liberalization include drug legalization, drug relegalization, and drug decriminalization. Proponents of drug liberalization may favor a regulatory regime for the production, marketing, and distribution of some or all currently illegal drugs in a manner analogous to that for alcohol, caffeine and tobacco.

<span class="mw-page-title-main">Medical cannabis in the United States</span>

In the United States, the use of cannabis for medical purposes is legal in 38 states, four out of five permanently inhabited U.S. territories, and the District of Columbia, as of March 2023. Ten other states have more restrictive laws limiting THC content, for the purpose of allowing access to products that are rich in cannabidiol (CBD), a non-psychoactive component of cannabis. There is significant variation in medical cannabis laws from state to state, including how it is produced and distributed, how it can be consumed, and what medical conditions it can be used for.

This is a history of drug prohibition in the United States.

<span class="mw-page-title-main">Kiki Camarena</span> DEA agent murdered by drug traffickers (1947–1985)

Enrique "Kiki" Camarena Salazar was an American intelligence officer for the Drug Enforcement Administration (DEA). In February 1985, Camarena was kidnapped by corrupt police officers hired by the Guadalajara Cartel. He was interrogated under torture and murdered. Three leaders of the cartel were eventually convicted in Mexico for Camarena's murder. The U.S. investigation into Camarena's murder led to ten more trials in Los Angeles for other Mexican nationals involved in the crime. The case continues to trouble U.S.–Mexican relations, most recently when Rafael Caro Quintero, one of the three convicted traffickers, was released from a Mexican prison in 2013. Caro Quintero again was captured by Mexican forces in July 2022.

During the administration of American President Jimmy Carter (1977–1981), the United States gave further consideration to the decriminalization of cannabis (marijuana), with the support of the president. However, law enforcement, conservative politicians, and grassroots parents' groups opposed this measure. The net result of the Carter administration was the continuation of the War on Drugs and restrictions on cannabis, while at the same time cannabis consumption in the United States reached historically high levels.

<span class="mw-page-title-main">Henry Giordano</span> American pharmacist, second Commissioner of the Federal Bureau of Narcotics

Henry Luke Giordano was an American pharmacist and federal agent who served as the second and last Commissioner of the Federal Bureau of Narcotics (FBN), from 1962 to 1968.

<span class="mw-page-title-main">John Ingersoll</span> American police officer and federal law enforcement agent (1929–2023)

Johnathan (Jack) E. Ingersoll was an American police officer and federal law enforcement agent. He was the first Chief of Police in Charlotte, North Carolina to use computers on the job. Ingersoll was the only Director of the Bureau of Narcotics and Dangerous Drugs (BNDD), and resigned amid the Watergate scandal. The BNDD was merged into the Drug Enforcement Administration two days after he departed from the government.

<span class="mw-page-title-main">John R. Bartels Jr.</span> American lawyer and first Administrator of the DEA

John Ries Bartels, Jr. is an American lawyer and was the first Administrator of the Drug Enforcement Administration. He was also the first Chief of the New Jersey Organized Crime Strike Force.

References

  1. ↑ "The Early Years" (PDF). Drug Enforcement Administration. January 1, 2020.
  2. 1 2 "The DEA Years" (PDF). Drug Enforcement Administration. Retrieved August 23, 2024.
  3. ↑ "John Finlator | High Times | Fall '74". High Times | The Complete Archive. Retrieved 2024-08-25.
  4. ↑ "News & Observer Index, 1926-1992 - View Cards". statelibrarync.org. Retrieved 2024-08-25.
  5. 1 2 3 4 5 6 7 8 9 "NARCOTICS BUREAU OFFICIAL JOHN FINLATOR DIES". Washington Post. August 19, 1990.
  6. ↑ "History of the Bureau of Diplomatic Security of the United States Department of State" (PDF). Department of State. October 1, 2011. p. 143.
  7. 1 2 3 "On this Day. March 7, 2019." DEA Museum. Accessed August 24, 2024.
  8. ↑ Drugs in American society: an encyclopedia of history, politics, culture, and the law. Internet Archive. Santa Barbara, California: ABC-CLIO. 2015. ISBN   978-1-61069-595-4.{{cite book}}: CS1 maint: others (link)
  9. ↑ "Linda Drouin bust April 1967". The Boston Globe. 1967-04-15. p. 3. Retrieved 2024-08-25.
  10. ↑ Finlator, John (April 1, 1967). "FDA Papers: drug abuse control" (PDF). quackwatch.
  11. 1 2 3 4 5 6 El-Sabawi, Taleed (2020-01-01). "Why the DEA & Not the FDA? Revisiting the Regulation of Potentially Addictive Substances". NEW YORK UNIVERSITY JOURNAL OF LAW & BUSINESS. 16: 317.
  12. 1 2 Federal Register 1968-04-10. 1968-04-10.
  13. ↑ Schmidt, Dana Adams (1972-02-12). "Government Study Urges Eased Laws on Marijuana". The New York Times. ISSN   0362-4331 . Retrieved 2024-08-25.
  14. ↑ SPECIAL RETIREMENT PROVISIONS FOR LAW ENFORCEMENT OFFICERS, FIREFIGHTERS AND AIR TRAFFIC CONTROLLERS Archived 25 September 2012 at the Wayback Machine , Defense Civilian Personnel Management Service, January 2011
  15. ↑ "Supernarc Quits To Join Other Side | Ann Arbor District Library". aadl.org. Retrieved 2024-08-25.
  16. 1 2 3 Anderson, Patrick (1973-01-21). "The pot lobby". The New York Times. ISSN   0362-4331 . Retrieved 2024-08-26.
  17. ↑ Stroup, Keith (2020-09-11). "A Founder Looks at 50: Some Early, Unexpected Supporters of Marijuana Decriminalization". NORML. Retrieved 2024-08-25.
  18. ↑ Dixon Evening Telegraph (1974-11-14). 1974-11-14.
  19. ↑ Stroup, Keith (2013). It's NORML to smoke pot : the 40-year fight for marijuana smokers' rights. Internet Archive. New York : Trans High Corporation. ISBN   978-1-893010-31-4.
  20. ↑ "The DEA Years" (PDF). Drug Enforcement Administration. Retrieved August 23, 2024.
  21. ↑ Finlator, John (1973). The drugged nation; a "narc's" story. Internet Archive. New York, Simon and Schuster. ISBN   978-0-671-21612-2.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.